A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 25, 2016

Study Completion Date

November 25, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Lebrikizumab

Lebrikizumab 125 milligrams (mg) will be administered subcutaneously once in every 4 weeks.

DRUG

Placebo

Matching placebo will be administered subcutaneously once in every 4 weeks.

Trial Locations (66)

1202

MHC - Sofia, EOOD, Sofia

1233

Fifth MHAT - Sofia EAD, Sofia

1878

Centro Respiratorio Quilmes, Quilmes

2233

National Multiprofile Transport Hospital Tzar Boris Ill; Clinic of Internal Diseases, Sofia

2400

Lungemedicinsk afd. L, Bispebjerg Hospital, København NV

2440

Farmakontroll Bt., Százhalombatta

2650

Hvidovre Hospital, Lungemedicinsk Afdeling, Hvidovre

2660

Dr. Kenessey Albert Korhaz Es Rendelointezet; Tudoosztaly (Pulmonolgy Dept ), Balassagyarmat

2900

Selye János Kórház és Rendelőintézet; Allergológiai Szakrendelés, Komárom

3000

Instituto Del Buen Aire, Santa Fe

3233

Matrai Állami Gyógyintézet ; Bronchológia, Mátraháza

3529

CRU Hungary Kft, Miskolc

4000

Investigaciones en Patologias Respiratorias, San Miguel de Tucumán

5000

Medical Center Tara OOD, Veliko Tarnovo

Odense Universitetshospital, Lungemedicinsk Forskningsenhed, Odense C

6000

"Medical Center Nov Rehabilitatsionen Tsentar, EOOD", Stara Zagora

7002

Specialized Hospital For Active Treatment of Pneumophthisiatric Diseases; Dept of Pneumonology, Rousse

7700

Mohacsi Korhaz, Mohács

9024

Petz Aladar Megyei Oktato Korhaz, Győr

9700

Markusovszky Egyetemi Oktatokorhaz; Tudogondozo, Szombathely

11435

ISA Clinical Research, Jamaica

14050

Centro Respiratorio de México, México

28054

Gastonia Pharmaceutical Research, Gastonia

29303

S. Carolina Pharmaceutical Research, Spartanburg

29707

Piedmont Research Partners LLC, Old Point Station

31405

Southeast Regional Res Group, Savannah

31904

Columbus Regional Research Institute, Columbus

32127

Progressive Medical Research, Port Orange

33126

Finlay Medical Research, Miami

34080

Centro de Investigacion y Atencion Integral Durango CIAID, Durango

35216

Achieve Clinical Research, LLC, Birmingham

44100

Instituto Jalisciense de Investigacion Clinica S.A. de C.V., Guadalajara

63141

The Clinical Research Ctr, St Louis

68000

Oaxaca Site Management Organization, Oaxaca City

70601

Centex Studies, Lake Charles

76800

Centro Integral Médico SJR SC, Querétaro

77030

Baylor College of Medicine; Ben Taub Hospital- Guntupalli, Houston

77062

Centex Studies, Houston

85381

Phoenix Medical Research Institute, LLC; Phoenix Medical Research Institute, LLC, Peoria

91324

California Medical Research Associates, Inc., Northridge

92262

Palmtree Clinical research Inc, Palm Springs

97504

Clinical Research Inst. of Southern Oregon, Pc, Medford

98208

Western Washington Medical Group, Everett

98405

MultiCare Health Center of Washington, Tacoma

99202

Premier Clinical Research, Spokane

105077

FSI Scientific Research Inst, Moscow

125367

Central Clinical Hospital #1 of RZhD JCS, Moscow

190068

"LLC Medical Center Alliance-Biomedical - Russian Group", Saint Petersburg

197089

"SBEI HPE The First St.Petersburg State Medical University n.a. acad. I.P.Pavlovaof MoH of RF", Saint Petersburg

St. Petersburg State Medical University n.a. I.P. Pavlov, Saint Petersburg

630008

Novosibirsk Municipal Clinical Hospital For Emergency Medicine #2, Novosibirsk

630087

State Novosibirsk Regional Clinical Hospital, Novosibirsk

630099

LLC Reafan, Novosibirsk

634050

Siberian State Medical University, Tomsk

08009

Comprehensive Clinical Research Inc., Berlin

C1426ABP

Centro Médico Dra de Salvo, Buenos Aires

CP 7600

Instituto Ave Pulmo, Mar del Plata

R2K 3S8

Concordia Hospital,Repiratory Research, Winnipeg

L8N 3Z5

McMaster University Medical Centre, Hamilton

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

M5T 3A9

Inspiration Research Limited, Toronto

05-825

Mazowieckie Centrum Badan Klinicznych S.C., Grodzisk Mazowiecki

90-153

Poradnia Pulmonologiczna dla Doroslych, Lódz

02-090

MS Clinsearch Specjalistyczny NZOZ Janusz Milanowski Katarzyna Szmygin-Milanowska Spółka Jawna, Lublin

41-707

Niepubliczny Zaklad Opieki Zdrowotnej PROFILAKTYKA Wladyslaw Pierzchala, Ruda Śląska

54-239

NZOZ Lekarze Specjalisci, Wroclaw

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter